Home
>
National Drug Code (NDC)
>
Cabergoline
Cabergoline - 49884-673-14 - (Cabergoline)
Drug Information of Cabergoline
| Product NDC: | 49884-673 |
| Proprietary Name: | Cabergoline |
| Non Proprietary Name: | Cabergoline |
| Active Ingredient(s): | .5 mg/1 & nbsp; Cabergoline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Cabergoline
| Product NDC: | 49884-673 |
| Labeler Name: | Par Pharmaceutical, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076310 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20051229 |
Package Information of Cabergoline
| Package NDC: | 49884-673-14 |
| Package Description: | 8 TABLET in 1 BOTTLE (49884-673-14) |
NDC Information of Cabergoline
| NDC Code | 49884-673-14 |
| Proprietary Name | Cabergoline |
| Package Description | 8 TABLET in 1 BOTTLE (49884-673-14) |
| Product NDC | 49884-673 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cabergoline |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20051229 |
| Marketing Category Name | ANDA |
| Labeler Name | Par Pharmaceutical, Inc. |
| Substance Name | CABERGOLINE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Ergolines [Chemical/Ingredient],Ergot Derivative [EPC] |
